Charlottesville, VA · Founded 2013 · Privately Held (backing)
Developer of a peptide therapy designed for the treatment of signs and symptoms of dry eye in primary sjögren's syndrome patients. TearSolutions is based in Charlottesville, VA and was founded in 2013. Its last reported valuation was $280 million in Nov 2024. It has raised $44.1 million across 11 recorded rounds; the latest was a $517,000 seed round in Oct 2025.
Last reported valuation
$280.0M
Oct 2026
Priced at
—
Total raised
$44.1M
Last round
Seed Round
Oct 2025
Team — not yet on record
No current team members for TearSolutions are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of TearSolutions with a free account
·The complete investor list: 13 names
·Watch TearSolutions: the Monday email on marks, rounds and moves
